(Press-News.org) A recently discovered protein complex known as STING plays a crucial role in detecting the presence of tumor cells and promoting an aggressive anti-tumor response by the body's innate immune system, according to two separate studies published in the Nov. 20 issue of the journal Immunity.
The studies, both from University of Chicago-based research teams, have major implications for the growing field of cancer immunotherapy. The findings show that when activated, the STING pathway triggers a natural immune response against the tumor. This includes production of chemical signals that help the immune system identify tumor cells and generate specific killer T cells. The research also found that targeted high-dose radiation therapy dials up the activation of this pathway, which promotes immune-mediated tumor control.
These findings could "enlarge the fraction of patients who respond to immunotherapy with prolonged control of the tumor," according to a commentary on the papers by the University of Verona's Vincenzo Bronte, MD. "Enhancing the immunogenicity of their cancers might expand the lymphocyte repertoire that is then unleashed by interference with checkpoint blockade pathways," such as anti-PD-1.
STING, short for STimulator of INterferon Genes complex, is a crucial part of the process the immune system relies on to detect threats--such as infections or cancer cells--that are marked by the presence of DNA that is damaged or in the wrong place, inside the cell but outside the nucleus.
Detection of such "cytosolic" DNA initiates a series of interactions that lead to the STING pathway. Activating the pathway triggers the production of interferon-beta, which in turn alerts the immune system to the threat, helps the system detect cancerous or infected cells, and ultimately sends activated T cells into the battle.
"We have learned a great deal recently about what we call checkpoints, the stumbling blocks that prevent the immune system from ultimately destroying cancers," said Thomas Gajewski, MD, PhD, professor of medicine and pathology at the University of Chicago and senior author of one of the studies. "Blockade of immune checkpoints, such as with anti-PD-1, is therapeutic in a subset of patients, but many individuals still don't respond. Understanding the role of the STING pathway provides insights into how we can 'wake up' the immune response against tumors. This can be further boosted by checkpoint therapies."
The two published studies, he said, help move this approach forward.
In a series of experiments in mice, both research teams found tumor cell-derived DNA could initiate an immune response against cancers. But when tested in mice that lacked a functional gene for STING, the immune system did not effectively respond.
"Innate immune sensing via the host STING pathway is critical for tumor control by checkpoint blockade," Gajewski's team noted in their paper. They found promising drugs known as checkpoint inhibitors--such as anti PD-1 or anti PD-L1, which can take the brakes off of an immune response--were not effective in STING-deficient mice. New agents that stimulate the STING pathway are being developed as potential cancer therapeutics.
A second University of Chicago team, led by cancer biologist Yang-Xin Fu, MD, PhD, professor of pathology, and Ralph Weichselbaum, MD, chairman of radiation and cellular oncology and co-director of the Ludwig Center for Metastasis Research, found that high-dose radiation therapy not only kills targeted cancer cells but the resulting DNA damage drives a systemic immune response.
"This result unifies traditional studies of DNA damage with newly identified DNA sensing of immune responses," Fu said.
"This is a previously unknown mechanism," Weichselbaum added.
In mice that lacked STING, however, there was no therapeutic immune response. The induction of interferons by radiation and consequent cancer cell killing, they conclude, depends on STING-pathway signaling.
They did find that combining cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), an earlier step in the STING pathway, with radiation, could greatly enhance the antitumor efficacy of radiation.
"This opens a new avenue to develop STING-related agonists for patients with radiation-resistant cancers," Fu said.
INFORMATION:
The studies were funded by the National Institutes of Health, the National Cancer Institute, Ludwig Cancer Research and the Foglia Family Foundation.
Additional authors of the Gajewski study, The STING pathway mediates innate immune sensing of immunogenic tumors, were Seng-Ryong Woo, Mercedes B. Fuertes, Leticia Corrales, Stefani Spranger, Michael J. Furdyna, Michael Y.K. Leung, Ryan Duggan, Ying Wang and Maria-Luisa Alegre from the University of Chicago; Glen N. Barber from the University of Miami; and , Katherine A. Fitzgerald from the University of Massachusetts.
Authors of the Fu-Weichselbaum paper, STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors, include Liufu Deng, Hua Liang, Meng Xu, Xuanming Yang, Byron Burnette, Ainhoa Arina, Helenna Mauceri, Michael Beckett, Thomas Darga, Xiaona Huang, and Thomas F. Gajewski from the University of Chicago; and Xiao-Dong Li and Zhijian J. Chen from the University of Texas Southwestern Medical Center.
Say you ignored one of those "this website is not trusted" warnings and it led to your computer being hacked. How would you react? Would you:
A. Quickly shut down your computer?
B. Yank out the cables?
C. Scream in cyber terror?
For a group of college students participating in a research experiment, all of the above were true. These gut reactions (and more) happened when a trio of Brigham Young University researchers simulated hacking into study participants' personal laptops.
"A lot of them freaked out--you could hear them audibly make noises from our observation ...
November 20, 2014, Chicago, IL - A team of researchers led by Ludwig Chicago's Yang-Xin Fu and Ralph Weichselbaum has uncovered the primary signaling mechanisms and cellular interactions that drive immune responses against tumors treated with radiotherapy. Published in the current issue of Immunity, their study suggests novel strategies for boosting the effectiveness of radiotherapy, and for combining it with therapies that harness the immune system to treat cancer.
"Much of the conversation about the mechanisms by which radiation kills cancer cells has historically focused ...
BOSTON -- Epithelial ovarian cancer is the most lethal cancer of the female reproductive organs, with more than 200,000 new cases and more than 125,000 deaths each year worldwide. Because symptoms tend to be vague, 80 percent of these cancers are not recognized until the disease has advanced and spread to other parts of the body. The standard treatment for advanced ovarian cancer includes high-dose chemotherapy, which often results in debilitating side effects and for which the five-year survival rate is only 35 percent.
Now new research in an animal model finds that ...
CORVALLIS, Ore. - Researchers from Oregon State University and other institutions have developed a new biomarker called "SDMA" that can provide earlier identification of chronic kidney disease in cats, which is one of the leading causes of their death.
A new test based on this biomarker, when commercialized, should help pet owners and their veterinarians watch for this problem through periodic checkups, and treat it with diet or other therapies to help add months or years to their pet's life.
Special diets have been shown to slow the progression of this disease once ...
RIVERSIDE, Calif. - How do galaxies like our Milky Way form, and just how do they evolve? Are galaxies affected by their surrounding environment? An international team of researchers, led by astronomers at the University of California, Riverside, proposes some answers.
The researchers highlight the role of the "cosmic web" - a large-scale web-like structure comprised of galaxies - on the evolution of galaxies that took place in the distant universe, a few billion years after the Big Bang. In their paper, published Nov. 20 in the Astrophysical Journal, they present observations ...
BOSTON (Nov. 20, 2014) Investigators at Massachusetts Eye and Ear and Harvard Medical School Department of Ophthalmology and colleagues reported the development and characterization of a comprehensive genetic test for inherited eye disorders in the online version of the Nature journal Genetics In Medicine today. The Genetic Eye Disease (GEDi) test includes all of the genes known to harbor mutations that cause inherited retinal degenerations, optic atrophy and early onset glaucoma. These disorders are important causes of vision loss, and genetic treatments such as gene ...
DURHAM, N.C. -- Displaced political aides looking for a new, nonpartisan job in the wake of the midterm power shuffle may fare better if they tone down any political references on their resumes, finds a new study from Duke University.
The study found that applicants who shared the minority partisan view of voters where a resume was sent were less likely to receive a callback from an employer than a candidate with a neutral resume.
Sharing information in line with the majority partisan view didn't give candidates an advantage, however.
"Our results showed that individuals ...
A new study from UNC's Frank Porter Graham Child Development Institute (FPG) reveals that disruptions in child care negatively affect children's social development as early as age 4. However, the study also shows that the effects of child care instability are not unduly large--and some types of instability appear to have no negative impact on children.
"Our findings showed that when young children moved between child care settings, these transitions negatively affected their social adjustment," said FPG investigator Mary Bratsch-Hines. "But when children had a history ...
The research found that incisor teeth grow quickly in the early stages of the second trimester of a baby's development, while molars grow at a slower rate in the third trimester. This is so incisors are ready to erupt after birth, at approximately six months of age, when a baby makes the transition from breast-feeding to weaning.
Weaning in humans takes place relatively early compared to some primates, such as chimpanzees. As a result, there is less time available for human incisors to form, so the enamel grows rapidly to compensate.
This research can increase our understanding ...
New Rochelle, NY, November 20, 2014-Women are more sensitive to the effects of cocaine and more susceptible to cocaine abuse than men. Cocaine's ability to disrupt a woman's estrus cycle may explain the sex differences in cocaine addiction, and new evidence that caffeine may be neuroprotective and able to block cocaine's direct effects on the estrus cycle reveals novel treatment possibilities, according to an article published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, ...